Clinical trial
A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese…
NCT00132561 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00132561 |
|---|---|
| Title | A Trial of Intermittent Treatment in the Prevention of Malaria in Senegalese Children |
| Official title | A Double-blind, Randomised, Placebo-controlled Trial to Measure the Potential of Intermittent Treatment With Artesunate Plus Sulphadoxine/Pyrimethamine (SP) to Reduce the Malaria Burden in Sub-Saharan Africa |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Institut de Recherche pour le Developpement, Senegal Institut de Recherche pour le Developpement Cheikh Anta Diop University, Senegal Ministry of Health, Senegal |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Sulfadoxine/pyrimethamine and artesunate |
| Enrollment | 1,200 |
| Start date | Jun 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Aug 22, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Senegal |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: